American Association for Clinical Chemistry (AACC)

AACC Releases Guidance Document on Using Point-of-Care Tests to Improve Patient Care

Newswise — WASHINGTON – AACC has issued a new guidance document detailing best practices that hospitals and other healthcare institutions should follow when running a point-of-care testing program. As point-of-care tests emerge for more and more conditions—including COVID-19—the guidance emphasizes that it is essential for laboratory professionals and clinicians to collaborate on point-of-care testing programs to ensure this testing benefits patients. 

Read the guidance document here: https://www.aacc.org/science-and-practice/aacc-academy-guidance/management-of-point-of-care-testing 

Point-of-care tests are clinical tests that can be performed near the patient, whether that’s in a doctor’s office, a pharmacy, or even at home, and they test for a variety of conditions from diabetes and cardiovascular disease to HIV. With their ability to rapidly deliver results, sometimes in mere minutes, these tests are revolutionizing healthcare by helping patients to get diagnosed and treated faster, while also making it easier for patients in remote areas to access medical testing. As transformative as these tests are, though, healthcare institutions need to exercise care in all aspects of their point-of-care testing programs to make sure they aren’t trading high quality test results for speed. Most recently, the risk of this happening was illustrated by issues with a point-of-care test that diagnoses COVID-19 in less than 15 minutes, but that was producing incorrect results because FDA initially cleared the instrument for use with an incompatible sample collection method.  

AACC’s guidance document, developed by experts in the association’s Academy, advises healthcare institutions on how to best adopt and oversee point-of-care testing in order to prevent problems like this and enhance patient care. One of the guideline’s major recommendations is that point-of-care testing programs should be managed by interdisciplinary committees that include all relevant stakeholders ranging from laboratory experts to clinicians. This is especially important since, unlike with standard laboratory testing, many of the operators who perform point-of-care testing are healthcare providers who don’t have clinical laboratory training. Close collaboration between laboratory professionals and providers is therefore crucial to the success of point-of-care testing programs. Laboratory professionals contribute invaluable expertise on the benefits and limitations of the tests themselves, while clinicians can provide vital insight into the testing needs of an institute’s patient population. 

This guidance also discusses the numerous factors healthcare institutions should consider when deciding whether or not to use a point-of-care test, one of the most important of which is determining if a faster test will actually impact patient outcomes. Once point-of-care testing is implemented, to make sure that it produces high quality results AACC’s guidance advises institutes to maintain ongoing training for point-of-care operators, to track specific point-of-care testing indicators that can flag areas in need of improvement, and to participate in a proficiency testing/external quality assessment program. 

“Point-of-care testing is a now proven approach that can provide faster turnaround of laboratory test results,” said the guidance document authors Drs. James H. Nichols, David Alter, Yu Chen, T. Scott Isbell, Ellis Jacobs, Norman Moore, and Zahra Shajani-Yi. “As manufacturers continue to introduce new point-of-care testing technologies, point-of-care testing is increasing in popularity, breadth of testing, and in the diversity of available clinical applications. Point-of-care testing is currently routine in all hospitals and has become the standard for patient care in a variety of other healthcare settings. Therefore, this guideline … will provide guidance to the laboratory, to clinicians, and to operators in how to best adopt point-of-care testing in their setting to optimize patient care.” 

About AACC

Dedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.aacc.org.

 

 




Filters close

Showing results

110 of 2528
Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

access_time Embargo lifts in 2 days
Embargo will expire: 12-Jul-2020 7:00 PM EDT Released to reporters: 10-Jul-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-Jul-2020 7:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 10-Jul-2020 9:00 AM EDT
Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression
University of Texas Health Science Center at Houston

A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at UTHealth.


Showing results

110 of 2528

close
0.98688